Newsroom
Sorted by: Latest
-
Samenvatting: Westlake Epoxy presenteert EpoVIVE™-portefeuille tijdens ECS 2025 voor een nieuw tijdperk van duurzame oplossingen
HOUSTON--(BUSINESS WIRE)--Westlake Corporation (NYSE: WLK) kondigde vandaag aan dat Westlake Epoxy verschillende nieuwe producten introduceert tijdens de European Coatings Show (ECS) 2025. Deze tentoonstelling vindt plaats van 25 tot 27 maart 2025 in Duitsland. Westlake Epoxy is dan met haar nieuwste ontwerpen aanwezig op stand nr. 5-349, waarmee het de robuustheid, veiligheid en prestaties verbetert. Bij Westlake gaan wij de uitdaging aan om de lat hoger te leggen in ons streven naar duurzaamh...
-
Avolon Announces Pricing of US$850 Million Senior Unsecured Notes Offering
DUBLIN--(BUSINESS WIRE)--Avolon Holdings Limited (“Avolon”), a leading global aviation finance company, announces the pricing of a private offering (the “Offering”) by its wholly owned subsidiary, Avolon Holdings Funding Limited, for a principal aggregate amount of US$850 million of 5.375% senior unsecured notes due 2030 (the “Notes”). The Notes will be fully and unconditionally guaranteed by Avolon, and by certain of its subsidiaries. The Offering is expected to close on or about 27 March 2025...
-
Davidson Bogel Real Estate Facilitates Sale of Premier Industrial Service Facility in Irving, TX
IRVING, Texas--(BUSINESS WIRE)--Davidson Bogel Real Estate (“DB2RE”) is pleased to announce the successful sale of 1600 E. Airport Freeway, a premier low-coverage industrial service facility in Irving, Texas. The property, which consists of two buildings totaling 20,800 square feet on 4.08 paved acres, was sold by Clay Cooley to Ambient Capital. DB2RE’s David Guinn represented the seller in the transaction. The property was directly acquired by Ambient Capital, which recognized the investment o...
-
CORRECTING and REPLACING Lincoln Financial Launches First Product in New Elite Indexed Universal Life Portfolio
RADNOR, Pa.--(BUSINESS WIRE)--Fifth paragraph, first sentence of release should read: Lincoln is adding new indexed accounts to the new Elite Indexed Universal Life Portfolio based on two S&P 500 indices, S&P 500 Dynamic Intraday TCA 15% Index and S&P 500 Daily Risk Control 10% Index, beginning with Lincoln WealthBuilderSM IUL. The updated release reads: LINCOLN FINANCIAL LAUNCHES FIRST PRODUCT IN NEW ELITE INDEXED UNIVERSAL LIFE PORTFOLIO Lincoln WealthBuilderSM IUL offers indexed...
-
Xcel Energy named one of the World’s Most Ethical Companies for sixth consecutive year
MINNEAPOLIS--(BUSINESS WIRE)--For a sixth consecutive year, Xcel Energy has been named a World’s Most Ethical Companies® honoree by Ethisphere....
-
Aviation Capital Group Announces Delivery of One A321neo to Wizz Air
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aviation Capital Group LLC (ACG), a premier global full-service aircraft asset manager, announced the delivery of one A321neo to Wizz Air. Powered by the ultra-efficient Pratt & Whitney GTF engines, this is the first aircraft scheduled to deliver to the airline as part of a multiple-aircraft sale-leaseback transaction between ACG and Wizz Air. “ACG is delighted to deliver this A321neo aircraft to Wizz Air. This is the beginning of our partnership with...
-
Novotech Named Best Contract Research Organization in Australia at Asia-Pacific Biopharma Excellence Awards 2025
SYDNEY--(BUSINESS WIRE)--Novotech Named Best Contract Research Organization (CRO) in Australia at Asia-Pacific Biopharma Excellence Awards 2025...
-
Novotech在2025年亞太生物製藥卓越獎評選中榮膺澳洲卓越受託研究機構獎
雪梨--(BUSINESS WIRE)--(美國商業資訊)-- Novotech是一家可提供全方位服務的國際性受託研究機構 (CRO) 和科學諮詢公司,始終致力於為生物科技公司以及中小型製藥公司提供加速藥物上市的解決方案,在2025年亞太生物製藥卓越獎 (ABEA) 評選中榮膺澳洲優秀受託研究機構獎。 Novotech總部位於澳洲,在全球設有30多個辦公據點,不僅是一家國際性CRO,更是亞太地區優秀的CRO企業。2025年亞太生物製藥卓越獎旨在表彰在臨床試驗等多個領域取得的卓越成就,充分肯定那些助力生物製藥創新的傑出組織、產業專家和前沿技術。所有獲獎者均由業界參與者投票選出,體現業內同行的高度認可。 在近日於新加坡金沙會議展覽中心舉行的頒獎典禮上,Novotech的臨床服務資深總監Chris Chong代表公司接受了該獎項。對於這份榮譽,Chong先生表達了誠摯的謝意:「感謝亞太生物製藥卓越獎對我們的認可。這份榮譽是對我們全球各地的團隊追求生物製藥創新的充分肯定。我們的客戶與合作夥伴將他們的研究計畫託付給我們,我們深感自豪,以加速新療法開發為己任。我們將繼續推動臨床研究,深化合作,持續...
-
诺为泰在2025年亚太生物制药卓越奖评选中荣膺澳大利亚卓越合同研究组织奖
悉尼--(BUSINESS WIRE)--(美国商业资讯)-- Novotech(诺为泰)是一家可提供全方位服务的国际性临床合同研究组织 (CRO) 和科学咨询公司,始终致力于为生物科技公司以及中小型制药公司提供加速药物上市的解决方案,在2025年亚太生物制药卓越奖 (ABEA) 评选中荣膺澳大利亚卓越合同研究组织奖。 诺为泰总部位于澳大利亚,在全球设有30多个办公室,不仅是一家国际性CRO,更是亚太地区优秀的CRO企业。2025年亚太生物制药卓越奖旨在表彰在临床试验等多个领域取得的卓越成就,充分肯定那些助力生物制药创新的杰出组织、行业专家和前沿技术。所有获奖者均由行业参与者投票选出,体现业内同行的高度认可。 在近日于新加坡金沙会议展览中心举行的颁奖典礼上,诺为泰的临床服务高级总监Chris Chong代表公司接受了该奖项。对于这份荣誉,Chong先生表达了诚挚的谢意:“感谢亚太生物制药卓越奖对我们的认可。这份荣誉是对我们全球各地的团队追求生物制药创新的充分肯定。我们的客户与合作伙伴将他们的研究项目托付给我们,我们深感自豪,以加速新疗法开发为己任。并将继续推动临床研究,深化合作,持续助...
-
Hamilton ETFs Announces March 2025 Cash Distributions
TORONTO--(BUSINESS WIRE)--Hamilton ETFs Announces March 2025 Cash Distributions...